News

A new study led by scientists at Scripps Research could help researchers develop personalized treatments for alcoholism and alcohol use disorder.

The new funding will support a five-year project, led by Professor Michael Farzan, to bring a potential HIV vaccine closer to human clinical trials.

"HIV is treatable but not curable—this remains a disease that causes a lot of suffering."

"What we've done is get to the root cause of T1D, and this allowed us to use strategies to prevent diabetes."

Burkle is Founder and Chairman of the Ronald W. Burkle Foundation, whose mission is to positively influence people around the world and their communities.

New research suggests that meth takes advantage of the brain’s natural learning process.

The researchers believe this new understanding of anti-CRISPR proteins may eventually lead to more sophisticated and efficient tools for gene editing.

"The ability to identify the glycan fingerprint on HIV’s glycoprotein will help us develop a vaccine that matches what is found on the virus."

Dawson brings to his new role more than 25 years’ experience at Scripps Research as a student, alumnus, faculty member and associate dean.

Scientists may have found a new tool for studying—and maybe even treating—Type 2 diabetes, the form of diabetes considered responsible for close to 95 percent of cases in the United States.

Two immune system molecules may be key to the development of drug resistance in estrogen-driven breast cancers.

The new method involves a class of pharmaceuticals known as antibody-drug conjugates (ADCs), which include some of the most promising next-generation antibody therapeutics for cancer.

Next, the researchers plan to further develop their molecule-screening strategy into a platform to test molecules against any form of RNA defect-related disease.

"This work at the molecular level has a real potential to benefit patients."

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have discovered how a protein called α2δ4 establishes proper vision.

Chemists at Scripps Research have devised a versatile molecule-building tool for creating new drugs and other chemical products.

"Given the great clinical demand for MRI for patients with a standard pacemaker or defibrillator, we wanted to determine the risk."

Results from a new Phase 3 study conducted by the Celgene Corporation demonstrate that ozanimod, a drug candidate originally discovered and optimized at Scripps Research, can reduce the frequency of multiple sclerosis relapse.

Scripps Research, one of the world's largest, private, non-profit research organizations, today announced the appointment of nine new members to its Board of Directors.

Is there a way to get metabolism to ramp up—even when it’s not cold out?

"At Scripps Florida we not only do great science, but we have even greater opportunities to collaborate on projects like this."

A Scripps Research team has described the role of two important molecules in the brain that work together to trigger intense anxiety.

"This method essentially mimics the ability of the enzymes in our cells to turn simple organic molecules into chiral molecules."